Introduction
Isolated immature thymocytes were the first model system widely utilized in the study of apoptosis, and arguably most of the information currently available on the biochemical and molecular mechanisms that regulate the process in mammalian cells is derived from this work. Apoptosis plays an important role in intrathymic T-cell development as the mechanism of cell death underlying the deletion of autoreactive T-cell precursors (negative selection). Thus, study of the biochemical and molecular mechanisms that regulate apoptosis in thymocytes remains relevant both for investigators interested in identifying general apoptosis control mechanisms and for immunologists interested in T-cell development.
From recent work it has become clear that both the programming of intrinsic apoptosis sensitivity and the triggering of the response are tightly regulated. A good deal is now known about the biochemical and molecular mechanisms controlling the triggering of apoptosis in CD4 + CD8 + thymocytes, but important questions concerning how these mechanisms differentially contribute to the differentiation or death of the cells in vivo remain, and relatively little is known about the programming of thymocyte apoptosis sensitivity. This article will present what is currently known about the mechanisms that regulate apoptosis in thymocytes within the context of how they may contribute to positive and negative selection.
Mechanisms that regulate apoptosis triggering
Most recent efforts concerned with identifying the biochemical and molecular mechanisms that regulate apoptosis in thymocytes have focused on apoptotic triggers. As a result, a number of physiological, physical and chemical stimuli have been identified that are all capable of inducing the morphological changes and endonuclease activation that characterize apoptosis in thymocytes (Table 1) .
Abbreviations used: CAMP, cyclic AMP; I'M, protein kinase A; PKC, protein kinase C; TCK, T-cell receptor.
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Where it has been investigated, the target population of cells is typically the CD4+CD8+ subset. The biochemical pathways that mediate these responses may be diverse, as discussed below.
Role of calcium
The fact that the endogenous endonuclease responsible for chromatin cleavage in apoptotic thymocytes depends upon Caz+ for its activation [3, 29] suggests that Ca2+ may be generally involved in regulating the process. Indeed, elevations in cytosolic Ca2+ concentration precede and may mediate subsequent endonuclease activation and cell death in thymocytes exposed to a variety of agents [4,5,7,10,14,1S,20] . This calcium sensitivity is perhaps best illustrated by the observation that calcium ionophores are capable of inducing apoptosis in the cells [2, 6, 7, 9] in a manner that is tightly linked to their effects on the cytosolic Ca2+ level [7] . However, the most physiologically significant of these pathways is likely to be the one directed by T-cell receptor (TCR) triggering, a response thought to underlie antigen-mediated elimination of auto- [36] provided the first evidence for a role for cyclic AMP (CAMP) in the regulation of apoptosis. Similarly, recent work has shown that R-series prostaglandins and other agents that elevate CAMP via diverse mechanisms stimulate endonuclease activation and cell death typical of apoptosis in thyomcytes [22.23] . Activation of CAMP-dependent protein kinase (protein kinase A, PKA) mediates the response [22] . Potential downstream targets of PKA include a transcription factor, CAMP response element binding protein (CKEB) and the glucocorticoid receptor, although direct implication of molecular targets for CAMP action awaits further investigation.
Role of protein kinase C 'Treatment of thymocytes with phorbol esters also results in DNA fragmentation and cell death typical of apoptosis [6, 9] . Inhibitors of protein kinase C (PKC) block the response [9] , suggesting that PKC activation represents a third signal transduction pathway capable of triggering apoptosis in thymo- [ 371, may be involved.
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Role of p53
The tumour suppressor protein pS3 has been shown to play a critical role in the DNA damage response, inhibiting cell-cycle progression and preventing mutation amplification [ 381. Work by Oren and colleagues [39] demonstrated that p53 can also trigger apoptosis in some tumour cells, a response that may be more generally involved in precipitating cell death following DNA damage. It has been known for some time that exposure of thymocytes to gamma irradiation or DNA-damaging chemotherapeutic drugs results in the induction of apoptosis [15] [16] [17] [18] [19] 25] . Recent work in mice homozygous for a p53 null mutation (p.53 'knockout' mice) has provided evidence for the molecular hasis for these responses by demonstrating that irradiation-and chemotherapy-induced thymocyte apoptosis are dependent upon p53 expression 116,171. Importantly, however, apoptotic pathways responding to glucocorticoid hormones or calcium ionophores are not altered in thymocytes from these animals, suggesting that the involvement of p53 may be limited to apoptosis triggered by DNA damage. The p53-dependent pathway is also likely to be involved in apoptosis in other tissues, i.e. the gut [40] , where DNA damage is thought to be the trigger.
Role of M y c
Induction of immediate early gene cfos, jun, myc) expression is a consequence of TCK triggering in resting mature T cells. Green, Cotter and coworkers [41] have shown that antisense oligonucleotides that block expression of the proto-oncogene c-myc abrogate DNA fragmentation and cell death normally observed in response to TCR triggering in a murine T-cell hybridoma, a thymus-derived cell type. However, like pS3, Myc is apparently not required for all pathways of apoptosis in thymocytes, in that glucocorticoid-induced apoptosis occurs efficiently in cells that lack the protein. Interestingly, other investigators have shown that overexpression of Myc can promote subsequent apoptosis induced by growth factor [42] or serum [43] withdrawal. It is therefore possible that Myc plays some role in the programming of cellular apoptosis sensitivity distinct from its involvement in various triggering pathways, a hypothesis that requires further study.
Role of Nur77
Given that inhibitors of protein or mRNA synthesis block apoptosis induced by glucocorticoids or TCR engagement in thymocytes, and previously characterized genes such as p.53 and myc appear to be required in at least some apoptotic triggering pathways, many investigators are attempting to identify novel genes that may also be involved in triggering the response. For example, Owens et al. [44] have identified two transcripts, termed RP-2 and RP-8, whose expression is elevated dramatically in thymocytes exposed to glucocorticoids or irradiation. Similarly, Baughman and co-workers [45] and Ishida and colleagues [46] have isolated mRNAs that are induced by glucocorticoids and TCR stimulation respectively. Recently, two groups have independently used subtractive hybridization techniques to demonstrate the involvement of an orphan member of the steroid hormone receptor superfamily, Nur77, in the pathway of apoptosis induced by TCR triggering in thymocytes [47, 48] . Importantly, expression of a dominant negative form of Nur77 or treatment of cells with antisense oligonucleotides specific for nur77 blocks TCRmediated but not glucocorticoid-induced apoptosis, indicating that functional Nur77 expression is required for the response. Whether or not the other novel genes isolated from apoptotic thymocytes are also required for cell death remains unknown.
The involvement of 'cross-talk'
Signal transduction pathways rarely act in isolation during physiological processes but rather exert interdependent effects on one another, a phenomenon that has been termed 'cross-talk'. In thymocytes, TCR triggering has been implicated in both positive and negative selection, a paradox that can be explained if one evokes the involvement of signalling pathway interactions that differ in the two situations. Emerging evidence indicates that some apoptotic triggering pathways can indeed block the effects of one another, while others may synergize to promote the response.
For years immunologists have known that productive T-cell activation requires at least two independent signals. Because treatment of T lymphocytes with a proper combination of calcium ionophore plus phorbol ester results in a potent activation response that recapitulates all of the downstream events observed following productive TCR triggering by cognate antigen, it has been suggested that a Ca2+ increase and PKC activation are the most critical components of the two pathways. Interestingly, treatment of mature T cells with CaZ+ ionophores alone induces a state of proliferative non-responsiveness (anergy), a process which may be involved in the maintenance of peripheral tolerance [49] . We speculated that thymocyte apoptosis and peripheral anergy may result from 'unbalanced' signal transduction, where a Caz+ increase occurs with insufficient PKC activation to promote activation [SO] . Indeed, phorbol esters inhibit apoptosis induced by calcium ionophores in thymocytes. In addition, the thymocyte co-mitogen interleukin-1 is also capable of blocking the effects of calcium ionophores, anti-TCR antibodies, or glucocorticoid hormones via a mechanism that appears to involve PKC activation [SO] . Precisely how the CaLf and PKC pathways interact is under investigation.
The pathways responding to glucocorticoid hormones and TCR triggering are also interactive.
In vitro, treatment of thymocytes or T-cell hybridomas with glucocorticoid hormones, TCR-specific antibodies or cognate antigen alone results in apoptosis, as discussed above. However, simultaneous TCR/glucocorticoid receptor triggering does not J. McConkey, unpublished work) animals. In addition, suboptimal doses of glucocorticoid hormones and anti-TCR antibodies synergize to promote thymocyte apoptosis in vivo [ll] . Thus, the pathways may both positively and negatively regulate one another, perhaps depending upon the dose of agonist. Alternatively, RlJ-486 may block TCRmediated apoptosis by partially activating the glucocorticoid receptor, which would indicate that interference between the pathways does not require glucocorticoid-receptor-dependent transcription. Clearly, further efforts are required to define the molecular basis for glucocorticoid receptor-TCR interactions in thymocytes.
In at least one case pathways that are capable of triggering thymocyte apoptosis independently of one another can synergize to promote the response.
Work by Bourgeois and colleagues demonstrated that cAMP promotes glucocorticoid receptor function [53] 
Role of bcl-2
Overexpression of the oncogene bcl-2 confers resistance to apoptosis in thymocytes exposed to diverse triggering mechanisms [ 591. Recent work has shown that Rcl-2 belongs to a growing family of evolutionarily conserved proteins that positively (Bax, Hcl-x,) or negatively (Hcl-2, Hcl-x,, ced-9) regulate cell death 1601. Given its ability to block diverse apoptotic triggering pathways, expression of Ikl-2 is a good candidate effector mechanism for desensitization of thymocytes to apoptosis triggering. Consistent with this idea, evidence is emerging that bcf-2 expression is differently regulated within different subpopulations of thymocytes. Precursor CD4-CD8-cells and mature CD4+CD8-/ CIl4 ~ CD8 + thymocytes express relatively abundant mRNA for bcl-2, whereas CD4 + CD8 + thymocytes express low levels of bcf-2 [61-631.
Whether or not differential Hcl-2 expression represents a general mechanism in apoptosis sensitivity programming in other cell types has not been established, but given the wide tissue expression of bcl-2 it remains an attractive possibility.
Precisely how Bcl-2 regulates apoptosis in thymocytes is still not known, although several possibilities are emerging. Hockenbery and colleagues [64] have shown that Bcl-2 can alter the manner in which mammalian cells deal with reactive oxygen species (oxidative stress). In addition, recent work has shown that Bcl-2 can physically associate with the R-ras GTP-binding protein [65] , and it is therefore possible that Hcl-2 either promotes or inhibits Ras activity. A third possibility suggested by the recent demonstration that Rcl-2 is found to be associated with the nuclear envelope [66] is that Hcl-2 directly modulates the nuclear mechanisms involved in apoptosis. Consistent with this, we have found that overexpression of Bcl-2 can inhibit or eliminate Ca2 Orrenius, unpublished work). Ongoing efforts in a number of independent laboratories are aimed at defining potential mechanisms involved in the effects of Rcl-2 on the nucleus and the other membraneous subcellular compartments in which the protein has been localized.
